View in EDS

A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma.

Saved in:
Bibliographic Details
Title: A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma.
Authors: Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tyshevich A; BostonGene Corporation, Waltham, Massachusetts., Shavronskaya D; BostonGene Corporation, Waltham, Massachusetts., Alesse J; BostonGene Corporation, Waltham, Massachusetts., English N; BostonGene Corporation, Waltham, Massachusetts., Sheehan E; BostonGene Corporation, Waltham, Massachusetts., Syzrantsev N; BostonGene Corporation, Waltham, Massachusetts., Nesmelov A; BostonGene Corporation, Waltham, Massachusetts., Zhuang TZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Westin JR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fayad LE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Henderson J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dent K; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., McChesney E; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas., Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Oct 01; Vol. 31 (19), pp. 4079-4088.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40729376
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Strati+P%22">Strati P</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Feng+L%22">Feng L</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Tyshevich+A%22">Tyshevich A</searchLink>; BostonGene Corporation, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Shavronskaya+D%22">Shavronskaya D</searchLink>; BostonGene Corporation, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Alesse+J%22">Alesse J</searchLink>; BostonGene Corporation, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22English+N%22">English N</searchLink>; BostonGene Corporation, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sheehan+E%22">Sheehan E</searchLink>; BostonGene Corporation, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Syzrantsev+N%22">Syzrantsev N</searchLink>; BostonGene Corporation, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Nesmelov+A%22">Nesmelov A</searchLink>; BostonGene Corporation, Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Zhuang+TZ%22">Zhuang TZ</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Chihara+D%22">Chihara D</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Westin+JR%22">Westin JR</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Ahmed+S%22">Ahmed S</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Fayad+LE%22">Fayad LE</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Henderson+J%22">Henderson J</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Dent+K%22">Dent K</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22McChesney+E%22">McChesney E</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Neelapu+SS%22">Neelapu SS</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Flowers+CR%22">Flowers CR</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2025 Oct 01; Vol. 31 (19), pp. 4079-4088.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40729376
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-25-1826
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4079
    Titles:
      – TitleFull: A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Strati P
      – PersonEntity:
          Name:
            NameFull: Feng L
      – PersonEntity:
          Name:
            NameFull: Tyshevich A
      – PersonEntity:
          Name:
            NameFull: Shavronskaya D
      – PersonEntity:
          Name:
            NameFull: Alesse J
      – PersonEntity:
          Name:
            NameFull: English N
      – PersonEntity:
          Name:
            NameFull: Sheehan E
      – PersonEntity:
          Name:
            NameFull: Syzrantsev N
      – PersonEntity:
          Name:
            NameFull: Nesmelov A
      – PersonEntity:
          Name:
            NameFull: Zhuang TZ
      – PersonEntity:
          Name:
            NameFull: Chihara D
      – PersonEntity:
          Name:
            NameFull: Westin JR
      – PersonEntity:
          Name:
            NameFull: Ahmed S
      – PersonEntity:
          Name:
            NameFull: Fayad LE
      – PersonEntity:
          Name:
            NameFull: Henderson J
      – PersonEntity:
          Name:
            NameFull: Dent K
      – PersonEntity:
          Name:
            NameFull: McChesney E
      – PersonEntity:
          Name:
            NameFull: Neelapu SS
      – PersonEntity:
          Name:
            NameFull: Flowers CR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2025 Oct 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 19
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1